HempFusion Wellness (TSX: CBD.U), along with its five-channel strategy, impressive line of products and historic first day of trading after completing its $17 million IPO, were the focus of a recent article. The article outlined the power of the company, noting that it was the first U.S.-based CBD company approved for listing directly on the TSX. The article recounted the company’s strength as a leader in the health and wellness CBD industry and called out its diverse portfolio of brands, including HempFusion CBD, Probulin Probiotics, Biome Research and HF Labs; the article also noted that the company offers four dozen products ranging from tinctures to proprietary over-the-counter (“OTC”) topicals with more than 30 additional products under development. The company’s product and market diversity is one of its strengths, particularly its Probulin Probiotics brand. Launched in 2013. Probulin has since become a wholly owned subsidiary of HempFusion and ranks as one of the fastest-growing probiotic companies in the natural product space. “Our products are based on exclusive and unique raw materials that are as close to the plants’ natural fingerprint as possible,” said HempFusion co-founder and CEO in the article, who also noted that “this IPO will accelerate our ability to scale HempFusion’s operations both domestically and internationally, drive accelerated growth within all our distribution channels, and significantly expand our marketing initiatives. A large percentage of the proceeds from the IPO will be earmarked for building out our ecommerce strategy.”
To view the full article, visit https://nnw.fm/hYx4X
About HempFusion Wellness Inc.
HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs (“SKUs”) including tinctures, proprietary FDA Drug Listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in store or online. For more information about the company, visit www.HempFusion.com.
NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://ibn.fm/HempFusion
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork